Form 8-K - Current report:
SEC Accession No. 0001847903-24-000192
Filing Date
2024-12-30
Accepted
2024-12-30 17:28:46
Documents
14
Period of Report
2024-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20241230.htm   iXBRL 8-K 37294
  Complete submission text file 0001847903-24-000192.txt   220248

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20241230.xsd EX-101.SCH 2618
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20241230_def.xml EX-101.DEF 16868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20241230_lab.xml EX-101.LAB 30840
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20241230_pre.xml EX-101.PRE 18275
16 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20241230_htm.xml XML 4497
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 241590666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)